What all the approved treatment target CD30?
Antibody Brand name Approval date Type Target Approved treatment(s)
Cancer immunotherapy
text text real text text text
1-1661124-1
Types of monoclonal antibodies
Cancer immunotherapy:Monoclonal antibodies
Alemtuzumab Campath 2001 humanized CD52 Chronic lymphocytic leukemia
Bevacizumab Avastin 2004 humanized vascular endothelial growth factor colorectal cancer
Brentuximab vedotin Adcetris 2011 chimeric CD30 Hodgkin lymphoma , Anaplastic large-cell lymphoma
Cetuximab Erbitux 2004 chimeric epidermal growth factor receptor colorectal cancer
Gemtuzumab ozogamicin Mylotarg 2000 humanized CD33 acute myelogenous leukemia (with calicheamicin )
Panitumumab Vectibix 2006 human epidermal growth factor receptor colorectal cancer
Rituximab Rituxan, Mabthera 1997 chimeric CD20 non-Hodgkin lymphoma
table_1661124_1
SELECT Approved treatment(s) FROM table WHERE Target = CD30
CD30